Jeffrey V Lazarus
@jvlazarus.bsky.social
Professor of Global Health
#LiverSky
#LiverSky
Reposted by Jeffrey V Lazarus
Five #CUNYSPH scholars have been named to Clarivate's 2025 Highly Cited Researchers list, the top 1% of researchers globally. Congratulations to Dean Ayman El-Mohandes, Prof. Levi Waldron , Prof. Jeffrey V Lazarus, Dist. Lecturer Ratzan, and Senior Scholar Kenneth Rabin.
cunysph.me/4obbhMa
cunysph.me/4obbhMa
Clarivate’s 2025 Highly Cited Researchers include five from CUNY SPH - CUNY Graduate School of Public Health & Health Policy
Five CUNY SPH faculty and senior scholars are featured among Clarivate’s Highly Cited Researchers for 2025. Dean Ayman El-Mohandes, Professor Jeffrey Lazarus, Senior Scholar Kenneth Rabin, Distinguished Lecturer Scott Ratzan, and Professor Levi Waldron made...
cunysph.me
December 3, 2025 at 3:30 PM
Five #CUNYSPH scholars have been named to Clarivate's 2025 Highly Cited Researchers list, the top 1% of researchers globally. Congratulations to Dean Ayman El-Mohandes, Prof. Levi Waldron , Prof. Jeffrey V Lazarus, Dist. Lecturer Ratzan, and Senior Scholar Kenneth Rabin.
cunysph.me/4obbhMa
cunysph.me/4obbhMa
Reposted by Jeffrey V Lazarus
🏈🩺 #CUNYSPH Prof. Bruce Y Lee explores NFL legend Dan Marino’s MASH (metabolic dysfunction–associated steatohepatitis) diagnosis in Forbes featuring insights from Prof. Jeffrey V Lazarus on the prevalence and public health risks of liver disease. cunysph.me/48CD1Vx
NFL Legend Dan Marino Talks About His MASH, Liver Disease Diagnosis
NFL Hall of Fame quarterback Dan Marino has revealed his metabolic dysfunction-associated steatohepatitis or MASH diagnosis. Here's what this liver disease is.
cunysph.me
October 7, 2025 at 2:25 PM
🏈🩺 #CUNYSPH Prof. Bruce Y Lee explores NFL legend Dan Marino’s MASH (metabolic dysfunction–associated steatohepatitis) diagnosis in Forbes featuring insights from Prof. Jeffrey V Lazarus on the prevalence and public health risks of liver disease. cunysph.me/48CD1Vx
Reposted by Jeffrey V Lazarus
A new Politico piece on chronic diseases quotes #CUNYSPH Prof. Jeffrey V Lazarus on how food environments shape health more than “individual choice”.
💬 “What are the options, what’s available, do you even have the ability to purchase healthy foods?”
Read more: cunysph.me/4gPQMT7
💬 “What are the options, what’s available, do you even have the ability to purchase healthy foods?”
Read more: cunysph.me/4gPQMT7
Chronic diseases are squeezing economies. Leaders don’t have much of a plan.
The United Nations General Assembly is expected to sign off on a watered-down commitment to tackle noncommunicable diseases.
cunysph.me
October 3, 2025 at 2:02 PM
A new Politico piece on chronic diseases quotes #CUNYSPH Prof. Jeffrey V Lazarus on how food environments shape health more than “individual choice”.
💬 “What are the options, what’s available, do you even have the ability to purchase healthy foods?”
Read more: cunysph.me/4gPQMT7
💬 “What are the options, what’s available, do you even have the ability to purchase healthy foods?”
Read more: cunysph.me/4gPQMT7
Reposted by Jeffrey V Lazarus
💬 'Wilton Park has shown to be a powerful outlet to reach world leaders and shape strategic health discussions.'
In our latest blog, @jvlazarus.bsky.social explains how his partnership with Wilton Park has delivered policy impact.
#WiltonPark80
🔗 wiltonpark.org.uk/idea/80-year...
In our latest blog, @jvlazarus.bsky.social explains how his partnership with Wilton Park has delivered policy impact.
#WiltonPark80
🔗 wiltonpark.org.uk/idea/80-year...
September 17, 2025 at 11:32 AM
💬 'Wilton Park has shown to be a powerful outlet to reach world leaders and shape strategic health discussions.'
In our latest blog, @jvlazarus.bsky.social explains how his partnership with Wilton Park has delivered policy impact.
#WiltonPark80
🔗 wiltonpark.org.uk/idea/80-year...
In our latest blog, @jvlazarus.bsky.social explains how his partnership with Wilton Park has delivered policy impact.
#WiltonPark80
🔗 wiltonpark.org.uk/idea/80-year...
Reposted by Jeffrey V Lazarus
🚨 Don't miss the third webinar of the #LIVERAIM series!
📹 youtube.com/watch?v=qdM_...
#SLDthinktank
@jvlazarus.bsky.social @ihieurope.bsky.social @easlnews.bsky.social @majathiele.bsky.social @salvatore-piano.bsky.social @aleksanderkrag.bsky.social
📹 youtube.com/watch?v=qdM_...
#SLDthinktank
@jvlazarus.bsky.social @ihieurope.bsky.social @easlnews.bsky.social @majathiele.bsky.social @salvatore-piano.bsky.social @aleksanderkrag.bsky.social
LIVERAIM webinar #3: A Deep Dive into Steatotic Liver Disease Policy and Regulatory Processes
YouTube video by LIVERAIM
youtube.com
July 28, 2025 at 5:29 PM
🚨 Don't miss the third webinar of the #LIVERAIM series!
📹 youtube.com/watch?v=qdM_...
#SLDthinktank
@jvlazarus.bsky.social @ihieurope.bsky.social @easlnews.bsky.social @majathiele.bsky.social @salvatore-piano.bsky.social @aleksanderkrag.bsky.social
📹 youtube.com/watch?v=qdM_...
#SLDthinktank
@jvlazarus.bsky.social @ihieurope.bsky.social @easlnews.bsky.social @majathiele.bsky.social @salvatore-piano.bsky.social @aleksanderkrag.bsky.social
Reposted by Jeffrey V Lazarus
😶Liver disease is often suffered in silence.
Stigma and shame block care.
💡It’s a chronic illness, not consequence of bad choices.
🩺Everyone deserves support.
At #LIVERAIM, we’re breaking the silence.
#EndTheStigma #LiverHealthMatters #HealthEquity
@ihieurope.bsky.social @easlnews.bsky.social
Stigma and shame block care.
💡It’s a chronic illness, not consequence of bad choices.
🩺Everyone deserves support.
At #LIVERAIM, we’re breaking the silence.
#EndTheStigma #LiverHealthMatters #HealthEquity
@ihieurope.bsky.social @easlnews.bsky.social
June 29, 2025 at 10:23 AM
😶Liver disease is often suffered in silence.
Stigma and shame block care.
💡It’s a chronic illness, not consequence of bad choices.
🩺Everyone deserves support.
At #LIVERAIM, we’re breaking the silence.
#EndTheStigma #LiverHealthMatters #HealthEquity
@ihieurope.bsky.social @easlnews.bsky.social
Stigma and shame block care.
💡It’s a chronic illness, not consequence of bad choices.
🩺Everyone deserves support.
At #LIVERAIM, we’re breaking the silence.
#EndTheStigma #LiverHealthMatters #HealthEquity
@ihieurope.bsky.social @easlnews.bsky.social
Reposted by Jeffrey V Lazarus
Happy to support and endorse the People First Liver Charter in
@natmed.nature.com www.nature.com/articles/s41...
We've always taken a sensitive approach to the language used in our journal, and will continue to do so. See this Editorial www.nature.com/articles/s41...
@natmed.nature.com www.nature.com/articles/s41...
We've always taken a sensitive approach to the language used in our journal, and will continue to do so. See this Editorial www.nature.com/articles/s41...
The People-First Liver Charter - Nature Medicine
Reducing the stigma and discrimination that people living with liver conditions experience requires rethinking how diagnoses, diseases, etiologies and circumstances are perceived — a shift that begins...
www.nature.com
June 9, 2025 at 12:31 PM
Happy to support and endorse the People First Liver Charter in
@natmed.nature.com www.nature.com/articles/s41...
We've always taken a sensitive approach to the language used in our journal, and will continue to do so. See this Editorial www.nature.com/articles/s41...
@natmed.nature.com www.nature.com/articles/s41...
We've always taken a sensitive approach to the language used in our journal, and will continue to do so. See this Editorial www.nature.com/articles/s41...
Reposted by Jeffrey V Lazarus
The People-First Liver Charter - opportunities for improving awareness, tackling stigma, building accessible care pathways, maintaining linkage to treatment/monitoring, & reducing health inequities.
🧪
Led by @jvlazarus.bsky.social
#NoHep #MedSky #HepSky #LiverSky
www.nature.com/articles/s41...
🧪
Led by @jvlazarus.bsky.social
#NoHep #MedSky #HepSky #LiverSky
www.nature.com/articles/s41...
The People-First Liver Charter - Nature Medicine
Reducing the stigma and discrimination that people living with liver conditions experience requires rethinking how diagnoses, diseases, etiologies and circumstances are perceived — a shift that begins...
www.nature.com
June 9, 2025 at 8:37 AM
The People-First Liver Charter - opportunities for improving awareness, tackling stigma, building accessible care pathways, maintaining linkage to treatment/monitoring, & reducing health inequities.
🧪
Led by @jvlazarus.bsky.social
#NoHep #MedSky #HepSky #LiverSky
www.nature.com/articles/s41...
🧪
Led by @jvlazarus.bsky.social
#NoHep #MedSky #HepSky #LiverSky
www.nature.com/articles/s41...
At the Global Think-tank on Steatotic Liver Disease, we launched the People-First Liver Charter
www.nature.com/articles/s41...
+ A call for doubling the diagnostic rate of at-risk MASH
www.thelancet.com/journals/lan...
#SLDthinktank #InMotionTogether #LiverSky
www.nature.com/articles/s41...
+ A call for doubling the diagnostic rate of at-risk MASH
www.thelancet.com/journals/lan...
#SLDthinktank #InMotionTogether #LiverSky
The People-First Liver Charter - Nature Medicine
Reducing the stigma and discrimination that people living with liver conditions experience requires rethinking how diagnoses, diseases, etiologies and circumstances are perceived — a shift that begins...
www.nature.com
June 8, 2025 at 1:27 PM
At the Global Think-tank on Steatotic Liver Disease, we launched the People-First Liver Charter
www.nature.com/articles/s41...
+ A call for doubling the diagnostic rate of at-risk MASH
www.thelancet.com/journals/lan...
#SLDthinktank #InMotionTogether #LiverSky
www.nature.com/articles/s41...
+ A call for doubling the diagnostic rate of at-risk MASH
www.thelancet.com/journals/lan...
#SLDthinktank #InMotionTogether #LiverSky
Reposted by Jeffrey V Lazarus
Congratulations to @jvlazarus.bsky.social on receiving the Eugene T. Davidson Public Service Award from the American Association of Clinical Endocrinology!
This award recognises exceptional contributions to clinical excellence, research, public health, and community engagement in #endocrinology.
This award recognises exceptional contributions to clinical excellence, research, public health, and community engagement in #endocrinology.
May 29, 2025 at 7:33 AM
Congratulations to @jvlazarus.bsky.social on receiving the Eugene T. Davidson Public Service Award from the American Association of Clinical Endocrinology!
This award recognises exceptional contributions to clinical excellence, research, public health, and community engagement in #endocrinology.
This award recognises exceptional contributions to clinical excellence, research, public health, and community engagement in #endocrinology.
Here we are in Spanish talking liver health. #WorldLiverDay
Hoy, #DíaMundialDelHígado, hablamos de la enfermedad hepática crónica más frecuente del mundo y cómo prevenirla.
¡Ciencia #EnMenosDeUnMinuto para que ganes un quesito verde en el Trivial Pursuit!
Puedes ver más de esta serie en nuestro #TikTok: 🟠https://bit.ly/ISGlobal_TikTok
¡Ciencia #EnMenosDeUnMinuto para que ganes un quesito verde en el Trivial Pursuit!
Puedes ver más de esta serie en nuestro #TikTok: 🟠https://bit.ly/ISGlobal_TikTok
April 19, 2025 at 4:47 PM
Here we are in Spanish talking liver health. #WorldLiverDay
Read about Chronic Liver Disease, MASLD/MASH, and the Global NCD Agenda in the context of the United Nations General Assembly High-level Meeting on NCDs this Sept. We need to take action every day and not just on #WorldLiverDay!
sldthinktank.com/un-hlm-2025-...
#liversky #SLDthinktank
sldthinktank.com/un-hlm-2025-...
#liversky #SLDthinktank
April 19, 2025 at 2:11 PM
Read about Chronic Liver Disease, MASLD/MASH, and the Global NCD Agenda in the context of the United Nations General Assembly High-level Meeting on NCDs this Sept. We need to take action every day and not just on #WorldLiverDay!
sldthinktank.com/un-hlm-2025-...
#liversky #SLDthinktank
sldthinktank.com/un-hlm-2025-...
#liversky #SLDthinktank
Reposted by Jeffrey V Lazarus
🌎Did you know 1 in 3 adults worldwide has #MASLD?
It’s tied to obesity, diabetes & high cholesterol, it can lead to fibrosis and cancer.
This #WorldLiverDay remember: #FoodIsMedicine!
💪Let's make #liverhealth a priority
@easlnews.bsky.social @ihieurope.bsky.social @europeliver.bsky.social
It’s tied to obesity, diabetes & high cholesterol, it can lead to fibrosis and cancer.
This #WorldLiverDay remember: #FoodIsMedicine!
💪Let's make #liverhealth a priority
@easlnews.bsky.social @ihieurope.bsky.social @europeliver.bsky.social
April 19, 2025 at 9:17 AM
🌎Did you know 1 in 3 adults worldwide has #MASLD?
It’s tied to obesity, diabetes & high cholesterol, it can lead to fibrosis and cancer.
This #WorldLiverDay remember: #FoodIsMedicine!
💪Let's make #liverhealth a priority
@easlnews.bsky.social @ihieurope.bsky.social @europeliver.bsky.social
It’s tied to obesity, diabetes & high cholesterol, it can lead to fibrosis and cancer.
This #WorldLiverDay remember: #FoodIsMedicine!
💪Let's make #liverhealth a priority
@easlnews.bsky.social @ihieurope.bsky.social @europeliver.bsky.social
"Food is Medicine" -But for whom? The accessibility problem in nutrition and liver health:
worldliverday.org/food-is-medi...
#WorldLiverDay #SLDthinktank #LiverSky
@easlnews.bsky.social @ebtapper.bsky.social @aleksanderkrag.bsky.social @debbieshawcross.bsky.social @melinamanolas.bsky.social
worldliverday.org/food-is-medi...
#WorldLiverDay #SLDthinktank #LiverSky
@easlnews.bsky.social @ebtapper.bsky.social @aleksanderkrag.bsky.social @debbieshawcross.bsky.social @melinamanolas.bsky.social
https://worldliverday.org/food-is-medici…
April 5, 2025 at 5:30 AM
"Food is Medicine" -But for whom? The accessibility problem in nutrition and liver health:
worldliverday.org/food-is-medi...
#WorldLiverDay #SLDthinktank #LiverSky
@easlnews.bsky.social @ebtapper.bsky.social @aleksanderkrag.bsky.social @debbieshawcross.bsky.social @melinamanolas.bsky.social
worldliverday.org/food-is-medi...
#WorldLiverDay #SLDthinktank #LiverSky
@easlnews.bsky.social @ebtapper.bsky.social @aleksanderkrag.bsky.social @debbieshawcross.bsky.social @melinamanolas.bsky.social
Reposted by Jeffrey V Lazarus
New paper from us in @jhepatology.bsky.social: www.journal-of-hepatology.eu/article/S016...
Causes of death in >13,000 persons with #MASLD - check it out #liversky. So proud of co-senior author Axel Wester and first author medical student Gabriel Issa for the work!
Causes of death in >13,000 persons with #MASLD - check it out #liversky. So proud of co-senior author Axel Wester and first author medical student Gabriel Issa for the work!
Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden
Data on cause-specific mortality in metabolic dysfunction-associated steatotic liver
disease (MASLD) are limited. We aimed to determine the rate and risk of death from
different causes in patients wit...
www.journal-of-hepatology.eu
March 24, 2025 at 7:51 PM
New paper from us in @jhepatology.bsky.social: www.journal-of-hepatology.eu/article/S016...
Causes of death in >13,000 persons with #MASLD - check it out #liversky. So proud of co-senior author Axel Wester and first author medical student Gabriel Issa for the work!
Causes of death in >13,000 persons with #MASLD - check it out #liversky. So proud of co-senior author Axel Wester and first author medical student Gabriel Issa for the work!
Reposted by Jeffrey V Lazarus
❓Did you miss the second #LIVERAIM webinar?
Check out our Youtube channel and discover what an #earlydiagnosis of #chronicliverdisease truly means for patients!
🎥 www.youtube.com/watch?v=jmw5...
@easlnews.bsky.social @ihieurope.bsky.social @europeliver.bsky.social
Check out our Youtube channel and discover what an #earlydiagnosis of #chronicliverdisease truly means for patients!
🎥 www.youtube.com/watch?v=jmw5...
@easlnews.bsky.social @ihieurope.bsky.social @europeliver.bsky.social
Early diagnosis of Chronic Liver Disease - What does it means for patients?
YouTube video by LIVERAIM
www.youtube.com
March 20, 2025 at 9:51 PM
❓Did you miss the second #LIVERAIM webinar?
Check out our Youtube channel and discover what an #earlydiagnosis of #chronicliverdisease truly means for patients!
🎥 www.youtube.com/watch?v=jmw5...
@easlnews.bsky.social @ihieurope.bsky.social @europeliver.bsky.social
Check out our Youtube channel and discover what an #earlydiagnosis of #chronicliverdisease truly means for patients!
🎥 www.youtube.com/watch?v=jmw5...
@easlnews.bsky.social @ihieurope.bsky.social @europeliver.bsky.social
Reposted by Jeffrey V Lazarus
Metabolic dysfunction-associated steatotic liver disease encompasses a spectrum from metabolic dysfunction-associated steatotic liver or isolated hepatic steatosis through to metabolic dysfunction-associated steatohepatitis (#MASH). #MASLD
https://www.nature.c...
https://www.nature.c...
March 12, 2025 at 6:24 PM
Metabolic dysfunction-associated steatotic liver disease encompasses a spectrum from metabolic dysfunction-associated steatotic liver or isolated hepatic steatosis through to metabolic dysfunction-associated steatohepatitis (#MASH). #MASLD
https://www.nature.c...
https://www.nature.c...
New Nature disease primer on #MASLD out now. MASLD affects 1 in 3 adults, yet it’s still underrecognized beyond #hepatology. That’s why our multidisciplinary team collaborated to cover epidemiology, diagnosis, treatment & prevention
🔗https://www.nature.com/articles/s41572-025-00599-1
#LiverSky
🔗https://www.nature.com/articles/s41572-025-00599-1
#LiverSky
In a related topic, more about MASLD in an amazing Nature Reviews Disease Primers article just published:
🔗 nature.com/articles/s41...
@jvlazarus.bsky.social
🔗 nature.com/articles/s41...
@jvlazarus.bsky.social
March 16, 2025 at 5:53 PM
New Nature disease primer on #MASLD out now. MASLD affects 1 in 3 adults, yet it’s still underrecognized beyond #hepatology. That’s why our multidisciplinary team collaborated to cover epidemiology, diagnosis, treatment & prevention
🔗https://www.nature.com/articles/s41572-025-00599-1
#LiverSky
🔗https://www.nature.com/articles/s41572-025-00599-1
#LiverSky
Reposted by Jeffrey V Lazarus
In a related topic, more about MASLD in an amazing Nature Reviews Disease Primers article just published:
🔗 nature.com/articles/s41...
@jvlazarus.bsky.social
🔗 nature.com/articles/s41...
@jvlazarus.bsky.social
March 12, 2025 at 10:14 AM
In a related topic, more about MASLD in an amazing Nature Reviews Disease Primers article just published:
🔗 nature.com/articles/s41...
@jvlazarus.bsky.social
🔗 nature.com/articles/s41...
@jvlazarus.bsky.social
Reposted by Jeffrey V Lazarus
📌Tomorrow is the day: don't miss the 2nd #LIVERAIM webinar!
✒️Register now! tinyurl.com/bdhyjv8e
@europeliver.bsky.social @easlnews.bsky.social @jvlazarus.bsky.social @aleksanderkrag.bsky.social @mkdmilan.bsky.social @majathiele.bsky.social @worldhepalliance.bsky.social
✒️Register now! tinyurl.com/bdhyjv8e
@europeliver.bsky.social @easlnews.bsky.social @jvlazarus.bsky.social @aleksanderkrag.bsky.social @mkdmilan.bsky.social @majathiele.bsky.social @worldhepalliance.bsky.social
March 2, 2025 at 6:10 PM
📌Tomorrow is the day: don't miss the 2nd #LIVERAIM webinar!
✒️Register now! tinyurl.com/bdhyjv8e
@europeliver.bsky.social @easlnews.bsky.social @jvlazarus.bsky.social @aleksanderkrag.bsky.social @mkdmilan.bsky.social @majathiele.bsky.social @worldhepalliance.bsky.social
✒️Register now! tinyurl.com/bdhyjv8e
@europeliver.bsky.social @easlnews.bsky.social @jvlazarus.bsky.social @aleksanderkrag.bsky.social @mkdmilan.bsky.social @majathiele.bsky.social @worldhepalliance.bsky.social
WHO "emphasizes the value of an integrated approach to HIV", drawing on our important evidence:
"Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (#INTEAFRICA): a pragmatic cluster-randomised, controlled trial"
www.thelancet.com/journals/lan... @gavinyamey.bsky.social
"Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (#INTEAFRICA): a pragmatic cluster-randomised, controlled trial"
www.thelancet.com/journals/lan... @gavinyamey.bsky.social
March 1, 2025 at 7:26 PM
WHO "emphasizes the value of an integrated approach to HIV", drawing on our important evidence:
"Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (#INTEAFRICA): a pragmatic cluster-randomised, controlled trial"
www.thelancet.com/journals/lan... @gavinyamey.bsky.social
"Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (#INTEAFRICA): a pragmatic cluster-randomised, controlled trial"
www.thelancet.com/journals/lan... @gavinyamey.bsky.social
Reposted by Jeffrey V Lazarus
⌛️4 day left!
Join 2nd #LIVERAIM webinar and learn what patients really think about #earlydiagnosis: the hopes, the fears, and the reality!
🗓️3 March 17:30-18:10 CET
👉Register now tinyurl.com/bdhyjv8e
@europeliver.bsky.social @easlnews.bsky.social @jvlazarus.bsky.social @aleksanderkrag.bsky.social
Join 2nd #LIVERAIM webinar and learn what patients really think about #earlydiagnosis: the hopes, the fears, and the reality!
🗓️3 March 17:30-18:10 CET
👉Register now tinyurl.com/bdhyjv8e
@europeliver.bsky.social @easlnews.bsky.social @jvlazarus.bsky.social @aleksanderkrag.bsky.social
February 27, 2025 at 6:29 PM
⌛️4 day left!
Join 2nd #LIVERAIM webinar and learn what patients really think about #earlydiagnosis: the hopes, the fears, and the reality!
🗓️3 March 17:30-18:10 CET
👉Register now tinyurl.com/bdhyjv8e
@europeliver.bsky.social @easlnews.bsky.social @jvlazarus.bsky.social @aleksanderkrag.bsky.social
Join 2nd #LIVERAIM webinar and learn what patients really think about #earlydiagnosis: the hopes, the fears, and the reality!
🗓️3 March 17:30-18:10 CET
👉Register now tinyurl.com/bdhyjv8e
@europeliver.bsky.social @easlnews.bsky.social @jvlazarus.bsky.social @aleksanderkrag.bsky.social
Reposted by Jeffrey V Lazarus
📣 The second #LIVERAIM webinar is on the way!
Early diagnosis of chronic liver disease - What does it mean for patients?
🗓️ 3 March 17:30-18:10 CET
🔗 Register now! tinyurl.com/4j97xhp9
#earlydiagnosis #changingtheparadigm
@easlnews.bsky.social @aleksanderkrag.bsky.social @jvlazarus.bsky.social
Early diagnosis of chronic liver disease - What does it mean for patients?
🗓️ 3 March 17:30-18:10 CET
🔗 Register now! tinyurl.com/4j97xhp9
#earlydiagnosis #changingtheparadigm
@easlnews.bsky.social @aleksanderkrag.bsky.social @jvlazarus.bsky.social
February 20, 2025 at 6:53 PM
📣 The second #LIVERAIM webinar is on the way!
Early diagnosis of chronic liver disease - What does it mean for patients?
🗓️ 3 March 17:30-18:10 CET
🔗 Register now! tinyurl.com/4j97xhp9
#earlydiagnosis #changingtheparadigm
@easlnews.bsky.social @aleksanderkrag.bsky.social @jvlazarus.bsky.social
Early diagnosis of chronic liver disease - What does it mean for patients?
🗓️ 3 March 17:30-18:10 CET
🔗 Register now! tinyurl.com/4j97xhp9
#earlydiagnosis #changingtheparadigm
@easlnews.bsky.social @aleksanderkrag.bsky.social @jvlazarus.bsky.social
Reposted by Jeffrey V Lazarus
Welcome immigrants from X interested in science to the friendlier skies of @bsky.app, as documented by a new @nature.com survey (but you already knew that 😉)
"Bluesky is much better for science. There is much less toxicity, misinformation, and distractions."
www.nature.com/articles/d41...
"Bluesky is much better for science. There is much less toxicity, misinformation, and distractions."
www.nature.com/articles/d41...
January 24, 2025 at 3:22 PM
Welcome immigrants from X interested in science to the friendlier skies of @bsky.app, as documented by a new @nature.com survey (but you already knew that 😉)
"Bluesky is much better for science. There is much less toxicity, misinformation, and distractions."
www.nature.com/articles/d41...
"Bluesky is much better for science. There is much less toxicity, misinformation, and distractions."
www.nature.com/articles/d41...
Dr @aleksanderkrag.bsky.social kicks off the #SLDsummit. First session is the SLD patient trajectory, proud to have contributed to it. We're joining after a fabulous visit to the Portuguese diabetes centre in Lisbon yesterday...
@easlnews.bsky.social
@easlnews.bsky.social
January 23, 2025 at 8:54 AM
Dr @aleksanderkrag.bsky.social kicks off the #SLDsummit. First session is the SLD patient trajectory, proud to have contributed to it. We're joining after a fabulous visit to the Portuguese diabetes centre in Lisbon yesterday...
@easlnews.bsky.social
@easlnews.bsky.social